Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inogen (INGN) EBT (2016 - 2026)

Inogen has reported EBT over the past 13 years, most recently at -$1.1 million for Q4 2025.

  • Quarterly EBT rose 89.47% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$17.1 million through Dec 2025, up 53.18% year-over-year, with the annual reading at -$17.1 million for FY2025, 53.18% up from the prior year.
  • EBT was -$1.1 million for Q4 2025 at Inogen, up from -$5.4 million in the prior quarter.
  • Over five years, EBT peaked at $71.9 million in Q4 2023 and troughed at -$56.5 million in Q4 2022.
  • The 5-year median for EBT is -$6.2 million (2024), against an average of -$7.0 million.
  • Year-over-year, EBT soared 409.93% in 2021 and then tumbled 486.58% in 2022.
  • A 5-year view of EBT shows it stood at -$14.5 million in 2021, then tumbled by 289.17% to -$56.5 million in 2022, then skyrocketed by 227.37% to $71.9 million in 2023, then plummeted by 114.02% to -$10.1 million in 2024, then skyrocketed by 89.47% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for INGN's EBT are -$1.1 million (Q4 2025), -$5.4 million (Q3 2025), and -$4.3 million (Q2 2025).